Markus Decker
Managing Partner
Affentranger Associates SA
Biotechnology
Aurélien Renaud
Managing Partner
Affentranger Associates SA
Biotechnology
Steven Brosi
Associate
Affentranger Associates SA
Biotechnology
Yanik Costa
Associate
Affentranger Associates SA
Biotechnology
Investors by Firm
- 01 Ventures Investors
- 1/0 Capital, LLC Investors
- 10X Venture Partners Investors
- 11-11 Ventures Investors
- 1315 Capital Investors
- 137 Ventures Investors
- 14W Investors
- 15th Rock Ventures Investors
- 1776 Investors
- 1855 Capital Investors
- 1984 Ventures Investors
- 1st Source Capital Corporation Investors
- 20/20 HealthCare Partners LLC Investors
- 2020 Ventures Investors
- 21 Centrale Partners Investors
- 21 Concordia Investors
- 21 Investimenti Investors
- 212 Ltd. Investors
- 22C Capital Investors
- 24Haymarket Investors
- 280 Capital Partners Investors
- 2bpartner Investors
- 2M Companies, Inc. Investors
- 2nd Generation Capital, LLC Investors
- 2x Consumer Products Growth Partners Investors
- 3 Rivers Capital Investors
- 32 Degrees Capital Investors
- 360° Capital Partners Investors
- 3d investors Investors
- 3E Bioventures Capital Investors
- 3G Capital Investors
- 3i Asia Ltd. Investors
- 3i Corporation Investors
- 3i Deutschland GmbH Investors
- 3i Europe plc Benelux Investors
- 3i Gestion S.A. Investors
- 3i Group plc Investors
- 3i India Pvt Ltd. Investors
- 3i Infrastructure plc Investors
- 3L Capital Investors
- 3P Equity Partners LLC Investors
- 3TS Capital Partners Investors
- 3W Partners Investors
- 406 Ventures, LLC Investors
- 42 Ventures, LLC Investors
- 424 Capital Investors
- 42CAP Manager GmbH Investors
- 4490 Ventures Investors
- 4BIO Capital Partners Investors
- 4C Capital LLC Investors
- 4D Global Energy Advisors Investors